Bryan Geoffrey Morton Insider Profile
4 Followers
Bryan Geoffrey Morton, former Director at Dechra Pharmaceuticals, holds 1.02M shares in ReNeuron Group (Ticker: RNUGF), holds 3.65K shares in Dechra Pharmaceuticals (Ticker: GB:DPH). Most recently, Bryan Geoffrey Morton Bought ― shares of ReNeuron Group on Aug 12, 2013 for an estimated value of $20.00K.
Bryan Geoffrey Morton's Trading History
| RNUGFReNeuron Group | Aug 12, 2013 | ― | Informative Buy | 20.00K | $50.80K | |
| DPHDechra Pharmaceuticals | May 16, 2012 | ― | Informative Buy | 2.52K | £140.92K |
You May Also Like
Bryan Geoffrey Morton insider profile FAQ
What is the percentage of profitable transactions made by Bryan Geoffrey Morton?
The percentage of profitable transactions made by Bryan Geoffrey Morton is 75%.
What is the average return per transaction made by Bryan Geoffrey Morton?
The average return per transaction made by Bryan Geoffrey Morton is 26.50%.
What stocks does Bryan Geoffrey Morton hold?
Bryan Geoffrey Morton holds: GB:DPH, RNUGF stocks.
What was Bryan Geoffrey Morton’s latest transaction?
Bryan Geoffrey Morton’s latest transaction was an Informative Buy of $20.00K.
What was Bryan Geoffrey Morton's most profitable transaction?
Bryan Geoffrey Morton’s most profitable transaction was an Informative Buy of RNUGF stock on August 12, 2013. The return on the trade was 28.50%.
What is Bryan Geoffrey Morton's role in Dechra Pharmaceuticals?
Bryan Geoffrey Morton's role in Dechra Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
